go-v.orgdoi

Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma

Dan Miao, Xu Qian, Yuan Zeng, Rui Zhao, Xian Song, Zhuoyan Chen, Liuwei Zeng, Luying Zhao, Zhuo Lin, Fujun Yu · Journal of Cancer · 2022

  • DOI 10.7150/jca.65080
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2022

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2022

Abstract

Background: Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, which makes the prognostic prediction challenging.Abnormal peroxisomes can promote the development of cancers.This study aimed to construct a prognostic model based on peroxisome-related genes and identify its prognostic prediction and immune distinction abilities in HCC.Methods: The prognostic model was constructed based on The Cancer Genome Atlas (TCGA) and The International Cancer Genome Consortium (ICGC).Kaplan-Meier curve, time-dependent receiver operating characteristic curve and Cox analysis were used to evaluate the model.The immune status, tumor microenvironment, drug sensitivity and expression levels of the mRNA and protein between HCC and adjacent non-tumorous tissues were analyzed and compared.Results: A prognostic model of 9 peroxisome-related genes was established and validated.Overall survival was markedly higher in the low-risk group relative to the high-risk group.The risk score was an independent prognostic factor.Tumor-related pathways were enriched in the high-risk group and the HCC patients in high-risk group showed depleted immune status.Furthermore, immune checkpointrelated genes, cell cycle-related genes, and multidrug resistance-related genes were overexpressed in the high-risk group.The expression levels of prognostic genes were negatively related to the anti-tumor drugs sensitivity.In addition, the expression level of each prognostic gene in HCC tissues was higher than that in adjacent non-tumorous tissues in an independent sample cohort and the similar results were found in most cancer types.Conclusion: A signature based on the nine peroxisome-related genes is a promising biomarker of HCC and is beneficial to the realization of individualized treatment.

Open the resolved locator · 10.7150/jca.65080

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:23 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v13p1418.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.